Seroprevalent study of cytomegalovirus infection in the regions of Jharkhand.

IF 1.1 Q4 PRIMARY HEALTH CARE
Anita Sundi, Nilamber Roopa, Piyalee Gupta, Sana Irfan, Tarun Kumar Kar
{"title":"Seroprevalent study of cytomegalovirus infection in the regions of Jharkhand.","authors":"Anita Sundi, Nilamber Roopa, Piyalee Gupta, Sana Irfan, Tarun Kumar Kar","doi":"10.4103/jfmpc.jfmpc_259_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Human Cytomegalovirus (HCMV) is a type of beta herpesvirus widespread in all human populations. It is estimated that up to 80-100% of adults worldwide and most infections are harmless and can cause severe health complications in infants, like hearing loss and developmental issues. Still, immunocompromised individuals can experience serious complications from the virus. Unfortunately, there is limited information on the prevalence of this virus in our country, and no studies have been reported on the rate of CMV transmission yet.</p><p><strong>Objectives: </strong>This study aims to evaluate the levels of IgM antibodies against Cytomegalovirus (CMV) in East Singhbhum, West Singhbhum, and Seraikela Kharsawan using an ELISA test.</p><p><strong>Methods: </strong>An indirect ELISA test was performed to detect anti-CMV IgM and the period of study was from January'2021 to June'2023.</p><p><strong>Results: </strong>The examination tested 55 people for the TORCH profile of CMV parameters from regions of East Singhbhum, West Singhbhum, and Seraikela Kharsawan. Here, 17 people (30.09%) were IgM positive by ELISA.</p><p><strong>Conclusions: </strong>The serological data confirms that CMV is not being monitored and recognized in the general population, which limits our study between CMV infection, disease, and clinically diagnosed outcomes. This understanding is crucial for the healthcare and policy sectors. Thus, we recommend implementing a surveillance and mindfulness program for at least one-fourth of the population in Jharkhand and continuing to explore and develop effective vaccines to control CMV infections.</p>","PeriodicalId":15856,"journal":{"name":"Journal of Family Medicine and Primary Care","volume":"13 9","pages":"4066-4070"},"PeriodicalIF":1.1000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504779/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Family Medicine and Primary Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jfmpc.jfmpc_259_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/11 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The Human Cytomegalovirus (HCMV) is a type of beta herpesvirus widespread in all human populations. It is estimated that up to 80-100% of adults worldwide and most infections are harmless and can cause severe health complications in infants, like hearing loss and developmental issues. Still, immunocompromised individuals can experience serious complications from the virus. Unfortunately, there is limited information on the prevalence of this virus in our country, and no studies have been reported on the rate of CMV transmission yet.

Objectives: This study aims to evaluate the levels of IgM antibodies against Cytomegalovirus (CMV) in East Singhbhum, West Singhbhum, and Seraikela Kharsawan using an ELISA test.

Methods: An indirect ELISA test was performed to detect anti-CMV IgM and the period of study was from January'2021 to June'2023.

Results: The examination tested 55 people for the TORCH profile of CMV parameters from regions of East Singhbhum, West Singhbhum, and Seraikela Kharsawan. Here, 17 people (30.09%) were IgM positive by ELISA.

Conclusions: The serological data confirms that CMV is not being monitored and recognized in the general population, which limits our study between CMV infection, disease, and clinically diagnosed outcomes. This understanding is crucial for the healthcare and policy sectors. Thus, we recommend implementing a surveillance and mindfulness program for at least one-fourth of the population in Jharkhand and continuing to explore and develop effective vaccines to control CMV infections.

恰尔肯德邦地区巨细胞病毒感染血清流行研究。
背景:人类巨细胞病毒(HCMV)是一种广泛存在于所有人群中的β疱疹病毒。据估计,全球有高达 80-100% 的成年人感染了该病毒,而且大多数感染是无害的,但会对婴儿的健康造成严重的并发症,如听力损失和发育问题。不过,免疫力低下的人也会因病毒而出现严重的并发症。遗憾的是,关于这种病毒在我国流行情况的资料有限,也没有关于 CMV 传播率的研究报告:本研究旨在使用 ELISA 检测法评估东辛布姆、西辛布姆和 Seraikela Kharsawan 的巨细胞病毒(CMV)IgM 抗体水平:方法:采用间接 ELISA 试验检测抗巨细胞病毒 IgM,研究时间为 2021 年 1 月至 2023 年 6 月:检查对来自东辛格布姆(East Singhbhum)、西辛格布姆(West Singhbhum)和Seraikela Kharsawan地区的55人进行了CMV参数TORCH图谱检测。其中,17 人(30.09%)通过 ELISA 检测呈 IgM 阳性:血清学数据证实,CMV 在普通人群中未得到监测和识别,这限制了我们对 CMV 感染、疾病和临床诊断结果之间关系的研究。这种认识对医疗保健和政策部门至关重要。因此,我们建议对恰尔肯德邦至少四分之一的人口实施监测和认知计划,并继续探索和开发有效的疫苗来控制 CMV 感染。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
7.10%
发文量
884
审稿时长
40 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信